tiprankstipranks
pc:qnovi

Qnovia Inc

https://www.qnovia.com/
Qnovia Inc. is a pharmaceutical company specializing in the development of prescription inhaled smoking cessation medications. The company is advancing its RespiRx™ Nicotine Inhaler, which recently received clearance from the U.S. FDA for its Investigational New Drug application, towards commercialization in the UK.

Leadership & Board

Current Number of Employees13
Current LinkedIn Followers714

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$16M
Total Amount Raised$16M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$16M
Latest Funding Amount$16M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

Qnovia Inc had 13 employees as of May 4, 2026. The number of employees increased by 1 (8.33%) week-over-week.
13Latest Employee Count
1(8.33%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Qnovia Inc had 714 followers as of May 4, 2026. The number of followers increased by 5 (0.71%) week-over-week.
714Latest Followers Count
5(0.71%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series B
$16.00M

Investors

Investor Name
Funding Round

Related News and Analysis